Gabapentin for chronic pelvic pain in women (GaPP2): a multicentre, randomised, double-blind, placebo-controlled trial

Horne AW., Vincent K., Hewitt CA., Middleton LJ., Koscielniak M., Szubert W., Doust AM., Daniels JP., Abdi S., Acharya S., Al-Inizi S., Ball E., Baranowski A., Bhal N., Bhatia K., Bhattacharya S., Birch JV., Carpenter T., Chalhoub T., Cheong YC., Clark TJ., Cregg R., Dada TD., Datta D., Faraj R., Feltham MG., Gupta P., Hapangama D., Hardwick C., Hughes J., Khatri P., Kumar G., Leighton LJ., Majumder K., MacFarlane GJ., Mortimer A., Odedra S., Ramsay B., Raza A., Rea W., Roy S., Sajid A., Saraswat L., Shah A., Sivasamy J., Srivastava R., Stubbs C., Swaminathan A., Thampi P., Thanoon O., Thomas T., Tracey I., Underwood M., Willocks C., Williams ACDC., Wood S., Zondervan K.

DOI

10.1016/s0140-6736(20)31693-7

Type

Journal article

Journal

The Lancet

Publisher

Elsevier BV

Publication Date

09/2020

Volume

396

Pages

909 - 917

Permalink Original publication